Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 125 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Pamela S.

Canada

USD 125 /hr

Clinical Research Consultant | Trial Startup & Regulatory Specialist | Health Canada & Global Trial Operations

Profile Summary

I’m a PhD-trained clinical research consultant with over 10 years of experience managing regulated trials in both academic and sponsor environments. I specialize in clinical trial startup, regulatory strategy, and protocol and SOP development, with deep expertise in Health Canada CTA submissions and Canadian REB workflows. I’ve led multi-site trials in addiction, mental health, and acute care settings, and frequently collaborate with research teams across Canada and internationally. My services support early-phase sponsors, CROs, and academic researchers seeking startup guidance, regulatory alignment, or operational support. Whether you need full startup execution or targeted consulting (CTA review, protocol development/ review, SOP development, GCP guidance, etc.), I provide precise, collaborative, and efficient solutions.

Subject Matter Expertise

• ★ Clinical Trials
• ☆ IRB Applications
• ☆ Clinical Trial Design
• ☆ Clinical Data Management
• ☆ Clinical Trial Site Selection & Monitoring
• ☆ Psychiatry
• ☆ Addiction Psychiatry
• ☆ Psychopharmacology
• ☆ Regulatory Affairs
• ☆ Regulatory Writing
• ☆ Clinical Trial Documentation
• ☆ Clinical Trial Protocol Writing
• ☆ Technical & Scientific Writing
• ☆ Manuscript & Journal Article Writing
• ☆ Literature Review
• ☆ Systematic Literature Review

Services

• Writing
• Research
• Consulting

Writing Clinical Trial Documentation, Medical Writing, Non-Medical Regulatory Writing, Technical Writing

Research Scientific and Technical Research, Systematic Literature Review

Consulting Operations Consulting, Scientific and Technical Consulting, Regulatory Consulting

Work Experience

Clinical Research Manager

Centre for Addiction and Mental Health (CAMH)

February 2025 - Present

Clinical Trial Manager

Changemark Research & Evaluation

November 2023 - Present

Scientific Associate

Centre for Addiction and Mental Health (CAMH)

June 2023 - January 2025

Clinical Trials Lead

Huxley Health Inc.

June 2022 - November 2023

Research Program Manager

Sinai Health System

October 2019 - May 2022

Project Scientist

Centre for Addiction and Mental Health (CAMH)

January 2017 - September 2019

Postdoctoral Fellow

Centre for Addiction and Mental Health (CAMH)

April 2013 - December 2016

Education

Bachelor in Pharmacy

Universidade Federal do Mato Grosso do Sul - Brazil

March 2002 - December 2025

PhD in Neuroscience

Universidade Federal de São Paulo - Brazil

January 2010 - April 2013

Masters in Pharmacology

Universidade Federal do Paraná - Brazil

March 2006 - December 2007

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Pamela Sabioni, Kasunka Kankanam Gamage, Serena Tejpar, Umair Majid, Kirsten Dixon, Abhimanyu Sud (2023). Bridging the Macro-micro Divide: A Qualitative Meta-synthesis on the Perspectives and Experiences of Health Care Providers on the Extramedical Use and Diversion of Buprenorphine . Journal of Addiction Medicine.

Pamela Sabioni, Abhimanyu Sud, Fabio Salamanca-Buentello, Daniel Z. Buchman, Umair Majid (2022). Beyond harm-producing versus harm-reducing: A qualitative meta-synthesis of people who use drugs' perspectives of and experiences with the extramedical use and diversion of buprenorphine . Journal of Substance Abuse Treatment.

Pamela Sabioni, Fabio Salamanca-Buentello, Darren K. Cheng, Umair Majid, Ross Upshur, Abhimanyu Sud (2022). Mal/adaptations: A qualitative evidence synthesis of opioid agonist therapy during major disruptions . International Journal of Drug Policy.

Pamela Sabioni, Pablo Rusjan, Patricia Di Ciano, Esmaeil Mansouri, Isabelle Boileau, Alexia Laveillé, Marc Capet, Thierry Duvauchelle, Jean‐Charles Schwartz, Philippe Robert, et al. (2020). Exploring occupancy of the histamine H₃ receptor by pitolisant in humans using PET . British Journal of Pharmacology.

Pamela Sabioni, Cayley Russell, Maria Neufeld, Thepikaa Varatharajan, Farihah Ali, Sarah Miles, Joanna Henderson, Benedikt Fischer, Jürgen Rehm (2019). Assessing service and treatment needs and barriers of youth who use illicit and non-medical prescription drugs in Northern Ontario, Canada . PLOS ONE.

Pamela Sabioni, Thepikaa Varatharajan, Cayley Russell, Joanna Henderson, Benedikt Fischer, Sarah Miles, Jürgen Rehm (2019). Assessing service and treatment needs of young people who use illicit and non-medical prescription drugs living in Northern Ontario, Canada . F1000Research.

Pamela Sabioni, Bernard Le Foll (2019). Psychosocial and Pharmacological Interventions for the Treatment of Cannabis Use Disorder . Focus.

Pamela Sabioni, Suzanne Nielsen, Linda Gowing, Bernard Le Foll (2019). Pharmacotherapies for cannabis dependence . Cochrane Database of Systematic Reviews.

Sabioni P and Le Foll B. Psychosocial and pharmacological interventions for the treatment of cannabis use disorder [version 1; referees: 3 approved] F1000Research 2018, 7(F1000 Faculty Rev):173 (doi: 10.12688/f1000research.11191.1) .

Pamela Sabioni (2018). Psychosocial and pharmacological interventions for the treatment of cannabis use disorder . F1000Research.

Pamela Sabioni, Benedikt Fischer, Cayley Russell, Wim van den Brink, Bernard Le Foll, Wayne Hall, Jürgen Rehm, Robin Room (2017). Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations . American Journal of Public Health.

Pamela Sabioni, Suzanne Nielsen, Jose M Trigo, Mark A Ware, Brigid D Betz-Stablein, Bridin Murnion, Nicholas Lintzeris, Kok Eng Khor, Michael Farrell, Andrew Smith, et al. (2017). Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis . Neuropsychopharmacology.

Pamela Sabioni, Peter J Gates, Jan Copeland, Bernard Le Foll, Linda Gowing (2016). Psychosocial interventions for cannabis use disorder . Cochrane Database of Systematic Reviews.

Pamela Sabioni, Patricia Di Ciano, Bernard Le Foll (2016). Effect of a D3 receptor antagonist on context-induced reinstatement of nicotine seeking . Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Pamela Sabioni, Jonathan Bertram, Bernard Le Foll (2015). Off-Label Use of Medications for Treatment of Benzodiazepine Use Disorder . Current Pharmaceutical Design.

Pamela Sabioni, Luiz Henrique Junqueira Dieckmann, Anna Carolina Ramos, Eroy Aparecida Silva, Luis Pereira Justo, Iracema Francisco Frade, Altay Lino de Souza, José Carlos Fernandes Galduróz (2014). Effects of biperiden on the treatment of cocaine/crack addiction: A randomised, double-blind, placebo-controlled trial . European Neuropsychopharmacology.

Pamela Sabioni, Anna Ramos, Jose Galduroz (2013). The Effectiveness of Treatments for Cocaine Dependence in Schizophrenic Patients: A Systematic Review . Current Neuropharmacology.

Pamela Sabioni, Camila G. Moreira, Janaína K. Barbiero, Deborah Ariza, Patrícia A. Dombrowski, Mariza Bortolanza, Claudio Da Cunha, Maria A. B. F. Vital, Marcelo M. S. Lima (2012). Behavioral, Neurochemical and Histological Alterations Promoted by Bilateral Intranigral Rotenone Administration: A New Approach for an Old Neurotoxin . Neurotoxicity Research.

Pamela Sabioni, Vânia D’Almeida, Monica L. Andersen, Roberto Andreatini, José C.F. Galduróz (2012). SKF 38393 reverses cocaine-conditioned place preference in mice . Neuroscience Letters.

Pamela Sabioni, Irinéia P. Baretta, Ester M. Ninomiya, Lianna Gustafson, Ana Lúcia S. Rodrigues, Roberto Andreatini (2008). The antimanic-like effect of tamoxifen: Behavioural comparison with other PKC-inhibiting and antiestrogenic drugs . Progress in Neuro-Psychopharmacology and Biological Psychiatry.

BOOK CHAPTER

Pamela Sabioni, Suzanne Nielsen, Linda Gowing, Bernard Le Foll (2019). Pharmacotherapies for Cannabis Use Disorders: Clinical Challenges and Promising Therapeutic Agents . Handbook of Experimental Pharmacology.